{"id":"W4389883767","doi":"10.1016/j.msard.2023.105329","title":"Update on Long-Term Efficacy and Safety of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, Over 5 Years from an Ongoing Phase 2 Open-Label Extension","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Tyrosine-kinase inhibitor; Bruton's tyrosine kinase; Open label; Term (time); Extension (predicate logic); Tyrosine kinase; Pharmacology; Oncology; Adverse effect; Internal medicine; Receptor; Cancer; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004194383,0.0002816456,0.0005319525,0.0002559831,0.0002035559,0.00007717039,0.0001787412,0.0002706865,0.0001241492],"category_scores_gemma":[0.0003236676,0.0002437594,0.00006003365,0.0006061093,0.0003328827,0.000218316,0.0003805571,0.0003594297,0.00003895414],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004567195,"about_ca_system_score_gemma":0.0003788315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001400359,"about_ca_topic_score_gemma":0.0001575478,"domain_scores_codex":[0.9976854,0.0001163288,0.0005133427,0.0007583802,0.0004574875,0.0004690579],"domain_scores_gemma":[0.9984915,0.0003498518,0.0001471822,0.0005852947,0.00006844871,0.0003576775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02475059,0.008741388,0.02802311,0.0004380437,0.0008612264,0.000436906,0.003759301,0.0004314811,0.2969119,0.0001230886,0.002765829,0.6327572],"study_design_scores_gemma":[0.2545626,0.001926037,0.6908368,0.002285247,0.0002262512,0.00001425788,0.0002222601,0.04547654,0.003404312,0.00005481157,0.000518675,0.0004721328],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962403,0.001692318,0.000006746505,0.0004552353,0.0001714887,0.001112805,0.00010014,0.0001152526,0.0001057039],"genre_scores_gemma":[0.9918432,0.00713482,0.0001020368,0.0001579361,0.00004205193,0.00001965856,0.0004874962,0.00007403092,0.0001388333],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6628137,"threshold_uncertainty_score":0.9940221,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04704248551265507,"score_gpt":0.3317993253816995,"score_spread":0.2847568398690445,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}